摘要
目的探讨规范化胸痛中心建设在ST段抬高型心肌梗死救治和预后中的应用价值。方法选择2014年7月—2016年6月间通过中国胸痛中心论证收治的220例行直接经皮冠状动脉介入治疗的STEMT患者为A组,另选择2016年7月—2018年6月间严格按照"规范化胸痛中心建设"模式收治的329例行PICC术患者为B组,回顾分析患者临床资料,比较两组再灌注时间、住院病死率、心力衰竭发生率、住院时间、药占比和人均住院费用。结果A组再灌注时间(以门-球时间Door-to-Ballon,D-to-B)为(121. 09±67. 8) min,住院时间为(9. 18±5. 36) d,人均住院费用为(41 648. 56±17 645. 75)元,分别与B组(82. 18±42. 7) min、(7. 80±3. 26) d和(38 777. 53±11 804. 41)元相比较,差异存在统计学意义(P <0. 05); A组住院病死率为3. 18%,药占比为18. 48%,较B组的2. 74%和15. 05%,无统计学差异(P> 0. 05);对两组心力衰竭发生率进行比较,数据差异存在统计学意义(P <0. 05)。结论规范化胸痛中心建设可缩短STEMI患者再灌注时间、住院时间,节省住院费用,降低住院病死率、心力衰竭发生率和药占比,推广应用价值明显。
Objective To compare the value of standardized construction of chest pain center for the treatment and prognosis of patients with ST-segment elevation myocardial infarction （STEMI）. Methods 220 patients having undergone primary percutaneous coronary intervention （PPCI） from July 2014 to June 2016 in our hospital were selected as group A, while another 329 patients who had undergone PICC from July 2016 to June 2018 were selected as group B in a strict model of “standardized chest pain center construction”. The clinical data of the patients were retrospectively analyzed and other data such as time of reperfusion, mortality, incidence of heart failure, time of admission, drug proportion and per capita costs of hospitalization were compared between the two groups. Results There were significant differences between group A and B in terms of the door-to-ballon time of reperfusion （121.09±67.8 min vs 82.18±42.7 min, P 〈0.05）min, hospitalization time （7.80±3.26 d vs 7.80±3.26 d, P 〈0.05） and average hospitalization cost （41 648.56±17 645.75 Yuan vs 38 777.53±11 804.41 Yuan, P 〈0.05）. But there were no differences between them in the mortality （3.18% vs 2.74%, P 〉0.05） and the drug proportion （18.48% vs 15.05%, P 〉0.05）. The difference of the incidence of heart failure between the two groups showed statistical significance. Conclusion The standardized construction of chest pain center can help shorten the time of reperfusion and hospitalization time, cut down the cost of hospitalization, and reduce fatality rate, the incidence of heart failure and the proportion of drugs among patients with STEMI, which is worthy of popularization and wide application.
作者
曹俊达
户洁
刘秋连
刘海龙
王琦
曹原
CAO Junda;HU Jie;LIU Qiulian;LIU Hailong;WANG Qi;CAO Yuan(Jiujiang NO.1 People＇s Hospital,Jiujiang 332000,China)
出处
《现代医院》
2018年第11期1576-1578,共3页
Modern Hospitals
基金
江西省卫生计生委科技计划项目(20187108)
关键词
规范化胸痛中心
STEMI
救治
预后效果
STEMI
Standardized Chest Pain Center
Treatment
Prognostic Effect
